These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4525300)

  • 1. A neurohypophyseal hormone analog with selective oxytocin-like activities and resistance to enzymatic inactivation: an approach to the design of peptide drugs.
    Walter R; Yamanaka T; Sakakibara S
    Proc Natl Acad Sci U S A; 1974 May; 71(5):1901-5. PubMed ID: 4525300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The synthesis and some pharmacological activities of[4-L-norvaline]-oxytocin and [4-L-norleucine]-oxytocin and their deamino analogs.
    Flouret G; Du Vigneaud V
    J Med Chem; 1969 Nov; 12(6):1035-8. PubMed ID: 5389145
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of decreasing the size of the ring present in deamino-oxytocin by one methylene group on its biological properties. The synthesis of 1-mercaptoacetic acid-oxytocin.
    Jarvis D; Du Vigneaud V
    J Biol Chem; 1967 Apr; 242(8):1768-71. PubMed ID: 6067284
    [No Abstract]   [Full Text] [Related]  

  • 4. Solid-phase syntheis and some pharmacological properties of [8-phenylalanine]-oxytocin.
    Baxter JW; Manning M; Sawyer WH
    Biochemistry; 1969 Sep; 8(9):3592-7. PubMed ID: 5387525
    [No Abstract]   [Full Text] [Related]  

  • 5. 4-Threonine analogues of neurohypophysial hormones withh selectively enhanced oxytocin-like activities.
    Sawyer WH; Manning M
    J Endocrinol; 1971 Jan; 49(1):151-65. PubMed ID: 5104449
    [No Abstract]   [Full Text] [Related]  

  • 6. The synthesis of (1-deamino,4-L-leucine)-oxytocin and (1-deamino,4-L-isoleucine)-oxytocin and some of their pharmacological properties.
    Takashima H; Hruby VJ; Du Vigneaud V
    J Am Chem Soc; 1970 Feb; 92(3):677-80. PubMed ID: 5460748
    [No Abstract]   [Full Text] [Related]  

  • 7. Crystalline deamino-dicarba-oxytocin. Preparation and some pharmacological properties.
    Yamanaka T; Hase S; Sakakibara S; Schwartz IL; Dubois BM; Walter R
    Mol Pharmacol; 1970 Sep; 6(5):474-80. PubMed ID: 5466703
    [No Abstract]   [Full Text] [Related]  

  • 8. Failure of 1-L-penicillamine-oxytocin and 1-deaminopenicillamine-oxytocin to inhibit the uterine effect of oxytocin in rabbits in vivo.
    Fuchs AR; Lopes AC
    Endocrinology; 1970 Jan; 86(1):71-6. PubMed ID: 5409455
    [No Abstract]   [Full Text] [Related]  

  • 9. An investigation of the natriuretic, antidiuretic and oxytocic actions of neurohypophysial hormones and related peptides: delineation of separate mechanisms of action and assessment of molecular requirements.
    Chan WY
    J Pharmacol Exp Ther; 1976 Mar; 196(3):746-57. PubMed ID: 1263121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 9-Deamidooxytocin, an analog of the hormone containing a glycine residue in place of the glycinamide residue.
    Ferrier BM; Du Vigneaud V
    J Med Chem; 1966 Jan; 9(1):55-7. PubMed ID: 6006226
    [No Abstract]   [Full Text] [Related]  

  • 11. Syntheses and pharmacological properties of selenium isologs of oxytocin and deamino-oxytocin.
    Walter R; Chan WY
    J Am Chem Soc; 1967 Jul; 89(15):3892-8. PubMed ID: 6068786
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study of the effects of using uterine stimulants on milk secretion during delivery].
    Pei JL; Zhao DF
    Zhonghua Hu Li Za Zhi; 1996 Jul; 31(7):384-5. PubMed ID: 9295487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid-phase synthesis of (4-threonine)-oxytocin. A more potent and specific oxytocic agent than oxytocin.
    Manning M; Coy E; Sawyer WH
    Biochemistry; 1970 Sep; 9(20):3925-30. PubMed ID: 5533681
    [No Abstract]   [Full Text] [Related]  

  • 14. 4-Threonine-oxytocin: a more active and specific oxytocic agent than oxytocin.
    Manning M; Sawyer WH
    Nature; 1970 Aug; 227(5259):715-6. PubMed ID: 5432071
    [No Abstract]   [Full Text] [Related]  

  • 15. [Vasopressin and Oxytocin. Physiological and pharmacological basis for the clinical use of the posterior pituitary gland hormones].
    Rauch R
    Dtsch Med Wochenschr; 1969 Dec; 94(50):2611-4. PubMed ID: 4901915
    [No Abstract]   [Full Text] [Related]  

  • 16. Release of oxytocin and vasopressin in lactating rats after injection of carbachol into the third ventricle.
    Kuhn ER; McCann SM
    Neuroendocrinology; 1971; 8(1):48-58. PubMed ID: 5104566
    [No Abstract]   [Full Text] [Related]  

  • 17. The synthesis and some of the pharmacological properties of [4-L-isoleucine]-oxytocin and [4-L-leucine]-oxytocin.
    Hruby VJ; Flouret G; du Vigneaud V
    J Biol Chem; 1969 Jul; 244(14):3890-4. PubMed ID: 5817165
    [No Abstract]   [Full Text] [Related]  

  • 18. Oxytocin and neurohypophyseal peptides: spectral assignment and conformational analysis by 220 MHz nuclear magnetic resonance.
    Johnson LF; Schwartz IL; Walter R
    Proc Natl Acad Sci U S A; 1969 Dec; 64(4):1269-75. PubMed ID: 5271751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new approach to the inhibition of puerperal lactation.
    Rolland R; Schellekens L
    J Obstet Gynaecol Br Commonw; 1973 Nov; 80(11):945-51. PubMed ID: 4800555
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of modification at position 2 on the side-chain conformation in oxytocin analogs.
    Smiech B; Kaźmierkiewicz R; Lammek B
    Acta Biochim Pol; 2006; 53(1):113-20. PubMed ID: 16523218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.